Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1)

British Journal of Anaesthesia

Volumn 98, Issue 5, 2007, Pages 624-627

  Molina, A L ^a   de Boer, H D ^b,d   Klimek, M ^a   Heeringa, M ^c   Klein, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NV ORGANON   (Netherlands)

^d MARTINI HOSPITAL   (Netherlands)

Author keywords

Neuromuscular block, rocuronium; Neuromuscular relaxant, sugammadex; Reversal agent

Indexed keywords

MIDAZOLAM; OXYGEN; PARACETAMOL; PROPOFOL; ROCURONIUM; SUFENTANIL; SUGAMMADEX; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BLOOD SAMPLING; CASE REPORT; CONTINUOUS INFUSION; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; HEART RATE; HOSPITAL DISCHARGE; HUMAN; INFORMED CONSENT; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MONITORING; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; PREMEDICATION; PRIORITY JOURNAL; SIDE EFFECT; DRUG ANTAGONISM; DRUG EFFECT; MEDICATION ERROR; NEUROMUSCULAR SYNAPSE; PHYSIOLOGY;

ADULT; ANDROSTANOLS; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MEDICATION ERRORS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 34250350008     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem057     Document Type: Article

References (10)

1. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed 2002; 41: 266-70
2. Booij LHDJ, De Boer HD, Van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin Anesth Perioperative Med Pain 2002; 21: 92-8
3. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703
4. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth 2006; 96: 201-6
5. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ, Sugammadex, a new reversal agent for neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth 2006; 96: 473-9
6. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LHDJ. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized Rhesus monkeys. Anesthesiology 2006; 104: 718-23
7. -1) neuromuscular block by Org 25969: A multi center dose finding and safety study. Anesthesiology 2005; 103 A1117
8. Rex C, Khuenl-Brady K, Sielenkaemper A, Kjaer CC, Puehringer FK. Reversal of high-dose rocuronium (1.2 mg/kg) with Org 25969. Anesthesiology 2005; 103: A1129
9. Shields M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96: 36-43
10. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. Anesthesiology 2006; 104: 667-74